195 related articles for article (PubMed ID: 20732599)
21. A novel exon 3 mutation (D76V) in the SOD1 gene associated with slowly progressive ALS.
Segovia-Silvestre T; Andreu AL; Vives-Bauza C; Garcia-Arumi E; Cervera C; Gamez J
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):69-74. PubMed ID: 12215228
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
Urushitani M; Ezzi SA; Julien JP
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2495-500. PubMed ID: 17277077
[TBL] [Abstract][Full Text] [Related]
23. Genetic mapping of a mouse modifier gene that can prevent ALS onset.
Kunst CB; Messer L; Gordon J; Haines J; Patterson D
Genomics; 2000 Dec; 70(2):181-9. PubMed ID: 11112346
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the copper- and zinc-containing superoxide dismutase gene are associated with "Lou Gehrig's disease".
Nutr Rev; 1993 Aug; 51(8):243-5. PubMed ID: 8302496
[TBL] [Abstract][Full Text] [Related]
25. Degenerative myelopathy in the Collie breed: a retrospective immunohistochemical analysis of superoxide dismutase 1 in an affected Rough Collie, and a molecular epidemiological survey of the SOD1: c.118G>A mutation in Japan.
Kohyama M; Kitagawa M; Kamishina H; Kobatake Y; Yabuki A; Sawa M; Kakita S; Yamato O
J Vet Med Sci; 2017 Feb; 79(2):375-379. PubMed ID: 27941298
[TBL] [Abstract][Full Text] [Related]
26. Species-specific consequences of an E40K missense mutation in superoxide dismutase 1 (SOD1).
Draper ACE; Wilson Z; Maile C; Faccenda D; Campanella M; Piercy RJ
FASEB J; 2020 Jan; 34(1):458-473. PubMed ID: 31914665
[TBL] [Abstract][Full Text] [Related]
27. Structure, chromosomal location, and analysis of the canine Cu/Zn superoxide dismutase (SOD1) gene.
Green SL; Tolwani RJ; Varma S; Quignon P; Galibert F; Cork LC
J Hered; 2002; 93(2):119-24. PubMed ID: 12140271
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of dogs with degenerative myelopathy: A survey of neurologists and rehabilitation professionals.
Bouché TV; Coates JR; Moore SA; Faissler D; Rishniw M; Olby NJ
J Vet Intern Med; 2023; 37(5):1815-1820. PubMed ID: 37606360
[TBL] [Abstract][Full Text] [Related]
29. Degenerative myelopathy in a Bernese Mountain Dog with a novel SOD1 missense mutation.
Wininger FA; Zeng R; Johnson GS; Katz ML; Johnson GC; Bush WW; Jarboe JM; Coates JR
J Vet Intern Med; 2011; 25(5):1166-70. PubMed ID: 21848967
[No Abstract] [Full Text] [Related]
30. Degenerative myelopathy in German Shepherd Dog: comparison of two molecular assays for the identification of the SOD1:c.118G>A mutation.
Capucchio MT; Spalenza V; Biasibetti E; Bottero MT; Rasero R; Dalmasso A; Sacchi P
Mol Biol Rep; 2014 Feb; 41(2):665-70. PubMed ID: 24390315
[TBL] [Abstract][Full Text] [Related]
31. Degenerative Myelopathy in Hovawart Dogs: Molecular Characterization, Pathological Features and Accumulation of Mutant Superoxide Dismutase 1 Protein.
Mandrioli L; Gandini G; Gentilini F; Chiocchetti R; Turba ME; Avallone G; Pellegrino V; Menchetti M; Kobatake Y; Kamishina H; Cantile C
J Comp Pathol; 2021 Jan; 182():37-42. PubMed ID: 33494906
[TBL] [Abstract][Full Text] [Related]
32. Degenerative myelopathy in a SOD1 compound heterozygous Bernese mountain dog.
Pfahler S; Bachmann N; Fechler C; Lempp C; Baumgärtner W; Distl O
Anim Genet; 2014 Apr; 45(2):309-10. PubMed ID: 24450472
[No Abstract] [Full Text] [Related]
33. Up-regulated spinal microRNAs induce aggregation of superoxide dismutase 1 protein in canine degenerative myelopathy.
Nakata K; Namiki M; Kobatake Y; Nishida H; Sakai H; Yamato O; Urushitani M; Maeda S; Kamishina H
Res Vet Sci; 2021 Mar; 135():479-485. PubMed ID: 33261827
[TBL] [Abstract][Full Text] [Related]
34. T137A variant is a pathogenetic SOD1 mutation associated with a slowly progressive ALS phenotype.
Origone P; Caponnetto C; Verdiani S; Mantero V; Cichero E; Fossa P; Bellone E; Mancardi G; Mandich P
Amyotroph Lateral Scler; 2012 Jun; 13(4):398-9. PubMed ID: 22632445
[No Abstract] [Full Text] [Related]
35. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient.
Shook SJ; Pioro EP
Ann Neurol; 2009 Jan; 65 Suppl 1():S10-6. PubMed ID: 19191305
[TBL] [Abstract][Full Text] [Related]
36. Plasma microRNA miR-26b as a potential diagnostic biomarker of degenerative myelopathy in Pembroke welsh corgis.
Nakata K; Heishima K; Sakai H; Yamato O; Furusawa Y; Nishida H; Maeda S; Kamishina H
BMC Vet Res; 2019 Jun; 15(1):192. PubMed ID: 31182094
[TBL] [Abstract][Full Text] [Related]
37. Gene linked to Lou Gehrig's disease.
Marx J
Science; 1993 Mar; 259(5100):1393. PubMed ID: 8451634
[No Abstract] [Full Text] [Related]
38. Modeling Lou Gehrig's disease in the fruit fly.
McCabe ER
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8533-4. PubMed ID: 7567970
[No Abstract] [Full Text] [Related]
39. Canine hereditary ataxia.
Urkasemsin G; Olby NJ
Vet Clin North Am Small Anim Pract; 2014 Nov; 44(6):1075-89. PubMed ID: 25441626
[TBL] [Abstract][Full Text] [Related]
40. A possible therapeutic target for Lou Gehrig's disease.
Ray SS; Lansbury PT
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5701-2. PubMed ID: 15079068
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
